Abstract:George Tocu, 1, 2, &ast Raul Mihailov, 3, 4 Cristina Serban, 4, 5 Bogdan Ioan Stefanescu, 5, 6, &ast Dana Tutunaru, 1, 2 Dorel Firescu 4, 5, &ast 1 Department of Pharmaceutical Sciences, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University, Galați, Romania; 2 Clinical Laboratory of Medical Analysis, Emergency County Clinical Hospital "Sf. Ap. Andrei" Galati, Galați, Romania; 3 Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, Galați, Romania; 4 Department of Surgery, Emergency County Clinical Hospital "Sf. Ap. Andrei" Galati, Galați, Romania; 5 Department of Clinical Surgery, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, Galați, Romania; 6 Department of Obstetrics and Gynecology, Emergency County Clinical Hospital "Sf. Ap. Andrei" Galati, Galați, Romania &astThese authors contributed equally to this work Correspondence: Raul Mihailov, Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University, 47 Domneasca Street, Galați, 800008, Romania, Tel +40745250391, Email rau Cristina Serban, Department of Clinical Surgery, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University, 47 Domneasca Street, Galați, 800008, Romania, Tel +40728249228, Email Background: Sepsis affects over 30 million people worldwide each year, causing approximately 6 million deaths. Challenges in clinical diagnosis and the need for an early diagnosis to prevent mortality due to sepsis have led to dependence on inflammatory biomarkers like Procalcitonin (PCT), C-reactive protein (CRP), and Interleukin-6 (IL-6). Objective: This study was performed to observe the contribution of inflammatory biomarkers in the diagnosis and prognosis of patients with surgical sepsis. Methods: We performed a retrospective observational study in a Clinical Emergency Hospital, which included a number of 125 patients with surgical sepsis admitted between January 2020 and December 2021. The patients were included in the study based on the Sepsis-3 definition. PCT, CRP, IL-6, Sepsis-related Organ Failure Assessment (SOFA) score, Charlson Comorbidity Index (CCI), the time up to surgery, the days of treatment in Intensive Care Unit (ICU) and the total days of hospitalization had been statistically analyzed. Results: The mean age of all patients was 65.14 years. The mean value in all patients for PCT was 20.08 ng/mL, for CRP was 175.42 mg/l, and for IL-6 was 799.6 pg/mL. The strongest correlation between biomarkers was between CRP and IL-6 (r = 0.425; p < 0.0001). Of all biomarkers, the CRP correlated the strongest with patient outcomes (r = 0.544; p < 0.0001). The area under curve (AUC) for the mean values of the inflammatory biomarkers was calculated and the best diagnostic performance was for CRP with 0.816 (95% CI: 0.744– 0.887). Conclusion: CRP and IL-6 were the most efficient in sepsis diagnosis. The association of PCT, CRP and IL-6 has increased the range of certainty in sepsis diagnosis. CRP was the most efficient biomarker in the prognosis of sepsis. Keywords: inflammatory biomarkers, SOFA score, septic shock, surgical sepsis, postoperatively Sepsis is known as an organ dysfunction due to the host's inadequate response to infection, which endangers patients' lives. Septic shock is a subtype of sepsis that includes circulatory, cellular, and metabolic abnormalities which are profound enough to induce a great increase in the mortality rate. 1 Sepsis and especially septic shock still remain increased risk factors for mortality. 2,3 Sepsis affects over 30 million people worldwide each year, causing approximately 6 million deaths. 3 The incidence of sepsis varies between 20% and 80%, and of septic shock between 10% and 30%, while the mortality in sepsis goes up to 50%, and in the septic shock up to 63%. 4 Challenges in clinical diagnosis and the need for an early diagnosis to prevent mortality in sepsis have led to the dependence upon inflammatory biomarkers like Procalcitonin (PCT), C-reactive protein (CRP) and Interleukin-6 (IL-6), which are among the most used, both in diagnosis, and in the management of antibiotic therapy, evolution and prognosis. 5–8 The increase in the concentration of these biomarkers can suggest the occurrence of sepsis and the clinicians will be able to initiate the appropriate and early treatment and thus the mortality in sepsis could be significantly reduced. 9 PCT is -Abstract Truncated-

Diagnostic and prognostic value of MR-pro ADM, procalcitonin, and copeptin in sepsis

Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis

Midregional‐proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta‐analysis

Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?

The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial

Prognostic Value of Mid-Regional Proadrenomedullin Sampled at Presentation and after 72 Hours in Septic Patients Presenting to the Emergency Department: An Observational Two-Center Study

Clinical usefulness of biomarkers for diagnosis and prediction of prognosis in sepsis and septic shock

Midregional Proadrenomedullin (MRproADM) Serum Levels in Critically Ill Patients Are Associated with Short-Term and Overall Mortality during a Two-Year Follow-Up

Roc Curve Analysis Of The Significance Of Pct Combined With Mr-Proadm In The Early Diagnosis Of Childhood Sepsis

The Utility of C-Reactive Protein, Procalcitonin, and Leukocyte Values in Predicting the Prognosis of Patients with Pneumosepsis and Septic Shock

Comparison of presepsin and Mid-regional pro-adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta-analysis

The Prospective Analysis of Biomarkers in Sepsis: Correlation With Clinical Outcomes

Usefulness of mid-regional proadrenomedullin levels in the resuscitation phase of severely burned patients and its utility in early sepsis detection

The Contribution of Procalcitonin, C-Reactive Protein and Interleukin-6 in the Diagnosis and Prognosis of Surgical Sepsis: An Observational and Statistical Study

Evaluation of the Mortality in Emergency Department Sepsis score combined with procalcitonin in septic patients

Basal procalcitonin, C-reactive protein, interleukin-6, and presepsin for prediction of mortality in critically ill septic patients: a systematic review and meta-analysis

New Biomarker Candidates of Sepsis: Diagnostic and Prognostic Value of Presepsin, Angiopoietin 1 and 2

Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock

Infection markers as predictors of Bacteremia in an Intensive Care Unit: A prospective study

Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions

Mid-Regional Pro-Adrenomedullin as a Prognostic Factor for Severe COVID-19 ARDS